Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 17/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.67 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL791606 | 0.98 | SIGMAR1 (0.97) | SIGMAR1SLC6A3SLC6A4SLC6A2TP53 | |
| SCHEMBL13306955 | 0.85 | SIGMAR1 (0.73) | SIGMAR1SLC6A3 | |
| SCHEMBL7536460 | 0.84 | SIGMAR1 (1.00) | SIGMAR1SLC6A3SLC6A4SLC6A2TP53 | |
| SCHEMBL792219 | 0.83 | SIGMAR1 (0.71) | SIGMAR1SLC6A3 | |
| SCHEMBL7218181 | 0.83 | SIGMAR1 (0.97) | SIGMAR1SLC6A3SLC6A4SLC6A2TP53 | |
| SCHEMBL7217896 | 0.83 | SIGMAR1 (0.97) | SIGMAR1SLC6A3SLC6A4SLC6A2TP53 | |
| Hydrochloric Acid SCHEMBL8694185 | 0.82 | SIGMAR1 (0.69) | SIGMAR1SLC6A3 | |
| SCHEMBL17346425 | 0.80 | SIGMAR1 (0.67) | SIGMAR1 | |
| Demelverine SCHEMBL1516521 | 0.80 | SIGMAR1 (0.76) | SIGMAR1SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL791608 | 0.79 | SIGMAR1 (0.65) | SIGMAR1SLC6A3SLC6A4SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992022279-A2 | N-[ARYLETHYL]-N-ALKYL-2-(1-PYRROLIDINYL)ETHYLAMINE DERIVATIVES FOR CNS DISORDERS | G.D. SEARLE & CO. (US) | 1992-12-23 | — | — | WO | disclosed |
| EP-0518216-A2 | N-/Arylethyl/-N-alkyl-2-(1-pyrrolidinyl)ethylamine derivatives for CNS disorders | G.D. Searle & Co. (US) | 1992-12-16 | — | — | EP | disclosed |